Platelet Reactivity Inhibition Following Ticagrelor Loading Dose and One Year Outcome in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 03 Oct 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Ticagrelor (Primary)
Indications Acute coronary syndromes; Cardiovascular disorders; Stroke; Thrombosis
Focus Therapeutic Use

27 Jul 2019 Results published in the Journal of Thrombosis and Haemostasis.
06 Apr 2018 Status changed from recruiting to completed.
09 Nov 2015 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com